Euroanaesthesia 2014 Abstract Book European Journal Of

Total Page:16

File Type:pdf, Size:1020Kb

Euroanaesthesia 2014 Abstract Book European Journal Of Volume 31 | e-Supplement 52 | June 2014 www.ejanaesthesiology.com EUROPEAN JOURNAL OF ANAESTHESIOLOGY MAY 30 - JUNE 2 BERLIN, GERMANY European Journal V olume 31 e-Supplement 52 June 2014 of Euroanaesthesia2015 Anaesthesiology The European Anaesthesiology Congress Euroanaesthesia 2014 The European Anaesthesiology Congress Abstracts Programme Stockholm, Sweden, May 31 - June 3, 2014 Symposia Refresher Courses Workshops Industrial Symposia & Exhibition Abstract Presentations CME Accreditation EACCME - UEMS Registration P +32 (0)2 743 32 90 F +32 (0)2 743 32 98 E [email protected] www.esahq.org/Euroanaesthesia2015 Abstract submission from Saturday 1 November to Monday 15 December 2014 ISSN 0265-0215 BERLIN-A4-AD.indd 1 16/04/2014 14:43:37 ESA omslag.indd 1 European Journal of Anaesthesiology VolumeVolume 31 | 29, e-Supplement Supplement 52 50, | June 20142012 Abstracts and Programme EUROANAESTHESIA 20122014 The European Anaesthesiology Congress 31 MayParis, - 3 France June 2014 Stockholm,9-12 June Sweden 2012 European Journal of Anaesthesiology Editor-in-Chief Associate Editors Per H. Rosenberg Helsinki, Finland Martin R. Tramèr Geneva, Switzerland Bernd W. Böttiger Cologne, Germany Charles-Marc Samama Paris, France Malachy Columb Manchester, UK Francis Veyckemans Brussels, Belgium Stefan G. De Hert Ghent, Belgium Deputy Editors-in-Chief Pierre Diemunsch Strasbourg, France Methods, Statistics, Epidemiology Walid Habre Geneva, Switzerland Argyro Fassoulaki Athens, Greece Nadia Elia Geneva, Switzerland Bernhard Walder Geneva, Switzerland Thomas Fuchs-Buder Nancy, France Peter Kranke Würzburg, Germany Journal Manager Language Editors Patricia M. Lavand’homme Brussels, Belgium Bridget M. Benn Geneva, Switzerland Alan Aitkenhead Nottingham, UK Doris Østergaard Copenhagen, Denmark Gordon Lyons Leeds, UK Rolf Rossaint Aachen, Germany Michael H. Nathanson Nottingham, UK Matt Wiles, Sheffi eld, UK European Journal of Anaesthesiology is the offi cial publication of Special projects and reprints (non-U.S./Canada): the European Society of Anaesthesiology. The Journal publishes Silvia Serra, email: [email protected] original scientifi c work. Preference is given to experimental work or clinical observations in man, and to laboratory work of clinical Disclaimer relevance. Although every effort is made by the publisher and editorial board to see that no inaccurate or misleading data, opinion or statement Information for contributors appear in this journal, they wish to make it clear that the data and Papers should be submitted online at: www.editorialmanager.com/eja. opinions appearing in the articles and advertisements herein are the responsibility of the contributor or advertiser concerned. Accordingly, European Journal of Anaesthesiology (ISSN: 0265-0215) is pub- the publisher, the editorial board and their respective employees lished monthly by Lippincott Williams & Wilkins and distributed in the accept no liability for the consequences of any such inaccurate or US by Mercury Airfreight International, Inc., 365 Blair Road, Avenel, misleading data, opinion or statement. NJ 07001. Periodicals postage paid at Rahway, NJ. POSTMASTER: send address changes to European Journal of Anaesthesiology, PO Drugs and drug dosages Box 1550, Hagerstown, MD 21741. Readers are advised that new methods and techniques described involving drug usage should be followed only in conjunction with drug All correspondence should be addressed to the Editorial Offi ce: manufacturers’ own published literature. European Journal of Anaesthesiology, Lippincott Williams & Wilkins, 250 Waterloo Road, London, SE1 8RD, UK 2014 Subscription rates Publisher Ian Burgess Individual $484 (USA); $484 (Rest of the World). Institutional $1,418 Editorial Coordinator Anna Rutkowska (USA); $1,515 (Rest of the World). On-line only subscriptions for Production Editor Duncan Martin-Holloway Institutions are available through Ovid (www.ovid.com). Prices include handling and shipping, but not sales tax, e.g. VAT, GST, Copyright © 2014 by European Society of Anaesthesiology. All MVG, MWS, AST and regional sales tax. Where applicable, please add right reserved. No part of this publication may be reproduced, sales tax to the listed prices at the appropriate rate. (The Canadian GST stored in a retrieval system, or transmitted in any form or by of 7% will be added to the subscription price of all orders shipped to any means, electronic, mechanical, photocopying, recording Canada. Lippincott Williams & Wilkins’ GST Identifi cation Number is or otherwise without either the prior written permission of the 895524239.) Copies will be replaced without charge if the publisher Publisher or a licence permitting restricted copying issued by the receives a request within 90 days of the mailing date, both in the USA Copyright Licensing Authority and in the USA by the Copyright and worldwide. Clearance Center. Subscription information Printed on chlorine-free, recyclable paper from sustainable forests European Journal of Anaesthesiology, Subscription meeting the requirements of ISO 9706, ISO 14001 and ISO 9001 Department, Lippincott Williams & Wilkins, in Singapore by COS Printers Pte Ltd. Typeset by Thomson Digital 16522 Hunters Green Parkway, Hagerstown, Ltd., Noida Special Economic Zone, Noida, India. MD 21740-2116, USA, tel: + 1 301 223 2300; fax: + 1 301 223 Advertising enquiries The Point of Difference Ltd., 2320. In the USA, call toll-free on 1 800 638 3030. In Japan, contact tel: +44 (0) 20 8542 3200; fax: +44 (0) 20 8543 3810; Wolters Kluwer Health Japan Co, Ltd, 1-28-36 Hongo, Bunkyo-ku, e-mail:[email protected] Tokyo 113, Japan, tel: + 81 3 3817 5675; fax: + 81 3 3815 6776. Special projects and reprints (U.S./Canada): Alan Moore, email: [email protected] EUROANAESTHESIA 2014 Stockholm, Sweden, 31 May - 3 June 2014 The European Anaesthesiology Congress ABSTRACT PRESENTATION PROGRAMME Please note that all abstracts are presented as poster presentations: abstract presenters do not make a formal presentation of their abstract in a separate room, using audiovisual aids (except for the Best Abstract Prize Competition). Instead, two chairpersons will conduct, in front of each poster, a short discussion of each abstract with the presenter and the audience, for every abstract in that session. Poster presenters have been asked to stand by their poster for 45 minutes before and 30 minutes after their session, to address further questions. Date Time Reference Location Page ESA Best Abstract Prize Competition (BAPC) 02.06.2013 14:00-15:30 ESAPC1 Room 120 1 Subcommittee 1 - Evidence-based Practice and Quality Improvement 01.06.2014 10:30-12:00 01AP1 Poster Area - Row 1A 3 01.06.2014 14:00-15:30 01AP2 Poster Area - Row 2A 6 01.06.2014 16:00-17:30 01AP3 Poster Area - Row 1B 10 02.06.2014 12:15-13:45 01AP4 Poster Area - Row 1A 13 02.06.2014 14:00-15:30 01AP5 Poster Area - Row 2A 16 02.06.2014 16:00-17:30 01AP6 Poster Area - Row 1B 20 03.06.2014 08:30-10:00 01AP7 Poster Area - Row 1A 22 Subcommittee 2 - Ambulatory Anaesthesia 01.06.2014 10:30-12:00 02AP1 Poster Area - Row 3A 25 03.06.2014 08:30-10:00 02AP2 Poster Area - Row 3A 26 Subcommittee 3 - Monitoring: Equipment and Computers 01.06.2014 10:30-12:00 03AP1 Poster Area - Row 5A 29 01.06.2014 14:00-15:30 03AP2 Poster Area - Row 4A 32 01.06.2014 16:00-17:30 03AP3 Poster Area - Row 3B 35 02.06.2014 10:30-12:00 03AP4 Poster Area - Row 2B 38 02.06.2014 16:00-17:30 03AP5 Poster Area - Row 3B 43 03.06.2014 08:30-10:00 03AP6 Poster Area - Row 5A 46 Subcommittee 4 - Clinical and Experimental Circulation 01.06.2014 10:30-12:00 04AP1 Poster Area - Row 7A 50 01.06.2014 10:30-12:00 04AP2 Poster Area - Row 9A 54 01.06.2014 14:00-15:30 04AP3 Poster Area - Row 6A 56 01.06.2014 14:00-15:30 04AP4 Poster Area - Row 8A 60 01.06.2014 16:00-17:30 04AP5 Poster Area - Row 5B 64 01.06.2014 16:00-17:30 04AP6 Poster Area - Row 7B 67 01.06.2014 16:00-17:30 04AP7 Poster Area - Row 9B 71 Date Time Reference Location Page Subcommittee 5 - Respiration 31.05.2014 15:00-16:30 05AP1 Poster Area - Row 1A 76 03.06.2014 08:30-10:00 05AP2 Poster Area - Row 4B 78 03.06.2014 08:30-10:00 05AP3 Poster Area - Row 7A 81 03.06.2014 08:30-10:00 05AP4 Poster Area - Row 9A 85 Subcommittee 6 - Transfusion and Haemostasis 31.05.2014 15:00-16:30 06AP1 Poster Area - Row 3A 88 01.06.2014 14:00-15:30 06AP2 Poster Area - Row 10A 91 02.06.2014 10:30-12:00 06AP3 Poster Area - Row 6B 95 02.06.2014 12:15-13:45 06AP4 Poster Area - Row 3A 99 03.06.2014 08:30-10:00 06AP5 Poster Area - Row 12A 102 Subcommittee 7 – Neurosciences 01.06.2014 10:30-12:00 07AP1 Poster Area - Row 12A 107 02.06.2014 10:30-12:00 07AP2 Poster Area - Row 8B 110 02.06.2014 12:15-13:45 07AP3 Poster Area - Row 5A 114 02.06.2014 12:15-13:45 07AP4 Poster Area - Row 7A 117 02.06.2014 14:00-15:30 07AP5 Poster Area - Row 4A 119 02.06.2014 14:00-15:30 07AP6 Poster Area - Row 6A 122 Subcommittee 8 - Regional Anaesthesia 31.05.2014 15:00-16:30 08AP1 Poster Area - Row 5A 125 01.06.2014 10:30-12:00 08AP2 Poster Area - Row 20A 128 01.06.2014 14:00-15:30 08AP3 Poster Area - Row 11A 131 02.06.2014 12:15-13:45 08AP4 Poster Area - Row 9A 135 03.06.2014 08:30-10:00 08AP5 Poster Area - Row 14A 138 Subcommittee 9 – Pharmacology 01.06.2014 10:30-12:00 09AP1 Poster Area - Row 14A 141 01.06.2014 14:00-15:30 09AP2 Poster Area - Row 13A 143 01.06.2014 16:00-17:30 09AP3 Poster Area - Row 12B 147 02.06.2014 12:15-13:45 09AP4 Poster Area - Row 12A 151 02.06.2014 14:00-15:30 09AP5 Poster Area - Row 8A 154 02.06.2014 16:00-17:30 09AP6 Poster Area -
Recommended publications
  • Key Summary of German National Treatment Guidance for Hospitalized COVID‑19 Patients
    Infection https://doi.org/10.1007/s15010-021-01645-2 ORIGINAL PAPER Key summary of German national treatment guidance for hospitalized COVID‑19 patients Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021) Jakob J. Malin1 · Christoph D. Spinner2 · Uwe Janssens3 · Tobias Welte4 · Stefen Weber‑Carstens5 · Gereon Schälte6 · Petra Gastmeier7 · Florian Langer8 · Martin Wepler9 · Michael Westhof10 · Michael Pfeifer11,12 · Klaus F. Rabe13 · Florian Hofmann14 · Bernd W. Böttiger15 · Julia Weinmann‑Menke16 · Alexander Kersten17 · Peter Berlit18 · Marcin Krawczyk19 · Wiebke Nehls20 · Falk Fichtner21 · Sven Laudi21 · Miriam Stegemann22 · Nicole Skoetz23 · Monika Nothacker24 · Gernot Marx25 · Christian Karagiannidis26 · Stefan Kluge27 Received: 24 May 2021 / Accepted: 19 June 2021 © The Author(s) 2021, corrected publication 2021 Abstract Purpose This executive summary of a national living guideline aims to provide rapid evidence based recommendations on the role of drug interventions in the treatment of hospitalized patients with COVID-19. Methods The guideline makes use of a systematic assessment and decision process using an evidence to decision framework (GRADE) as recommended standard WHO (2021). Recommendations are consented by an interdisciplinary panel. Evidence analysis and interpretation is supported by the CEOsys project providing extensive literature searches and living (meta-) analyses. For this executive summary, selected key recommendations on drug therapy are presented including the quality of the evidence and rationale for the level of recommendation. Results The guideline contains 11 key recommendations for COVID-19 drug therapy, eight of which are based on systematic review and/or meta-analysis, while three recommendations represent consensus expert opinion. Based on current evidence, the panel makes strong recommendations for corticosteroids (WHO scale 5–9) and prophylactic anticoagulation (all hospital- ized patients with COVID-19) as standard of care.
    [Show full text]
  • Euroanaesthesia 2013 Abstract Book European Journal Of
    Volume 30 | e-Supplement 51 | June 2013 www.ejanaesthesiology.com EUROPEAN JOURNAL OF ANAESTHESIOLOGY MAY 31 - JUNE 3 STOCKHOLM, SWEDEN European Journal V olume 30 e-Supplement 51 June 2013 of Euroanaesthesia2014 Anaesthesiology The European Anaesthesiology Congress Euroanaesthesia 2013 The European Anaesthesiology Congress Abstracts Programme Barcelona, Spain, June 1-4, 2013 Symposia Refresher Courses Workshops Industrial Symposia & Exhibition Abstract Presentations CME Accreditation EACCME - UEMS Registration P +32 (0)2 743 32 90 F +32 (0)2 743 32 98 E [email protected] www.euroanaesthesia.org 5 Abstract submission from Friday 1 November to Sunday 15 December 2013 ISSN 0265-021 ESA omslag.indd 1 European Journal of Anaesthesiology Volume 30 | e-Supplement 51 | June 2013 Abstracts and Programme EUROANAESTHESIA 2013 The European Anaesthesiology Congress 1 - 4 June 2013 Barcelona, Spain European Journal of Anaesthesiology Editor-in-Chief Associate Editors Per H. Rosenberg Helsinki, Finland Martin R. Tramèr Geneva, Switzerland Bernd W. Böttiger Cologne, Germany Charles-Marc Samama Paris, France Malachy Columb Manchester, UK Francis Veyckemans Brussels, Belgium Stefan G. De Hert Ghent, Belgium Deputy Editors-in-Chief Pierre Diemunsch Strasbourg, France Methods, Statistics, Epidemiology Walid Habre Geneva, Switzerland Argyro Fassoulaki Athens, Greece Nadia Elia Geneva, Switzerland Bernhard Walder Geneva, Switzerland Thomas Fuchs-Buder Nancy, France Peter Kranke Würzburg, Germany Journal Manager Language Editors Patricia M. Lavand’homme Brussels, Belgium Bridget M. Benn Geneva, Switzerland Alan Aitkenhead Nottingham, UK Doris Østergaard Copenhagen, Denmark Gordon Lyons Leeds, UK Rolf Rossaint Aachen, Germany Michael H. Nathanson Nottingham, UK Matt Wiles, Sheffi eld, UK European Journal of Anaesthesiology is the offi cial publication of Advertising enquiries The Point of Difference Ltd., the European Society of Anaesthesiology.
    [Show full text]
  • Obstetrics Current Awareness Newsletter May 2017 (Bimonthly)
    1 Obstetrics Current Awareness Newsletter May 2017 (Bimonthly) 2 Training Calendar 2017 All sessions are 1 hour May (13.00) Fri 26th Interpreting Statistics Wed 31st Critical Appraisal June (12.00) Thurs 1st Literature Searching Thurs 8th Interpreting Statistics Tues 13th Critical Appraisal Thurs 29th Literature Searching Your Outreach Librarian – Helen Pullen Whatever your information needs, the library is here to help. Just email us at [email protected] Outreach: Your Outreach Librarian can help facilitate evidence-based practice for all in the team, as well as assisting with academic study and research. We also offer one-to-one or small group training in literature searching, critical appraisal and medical statistics. Get in touch: [email protected] Literature searching: We provide a literature searching service for any library member. For those embarking on their own research it is advisable to book some time with one of the librarians for a one-to-one session where we can guide you through the process of creating a well-focused literature research. Please email requests to [email protected] 3 Contents The Latest Evidence NICE………………………………………………………………………………………………………4 The Cochrane Library………………………………………………………………………….4-5 UpToDate……………………………………………………………………………………………5-6 NHS ‘Behind the Headlines’……………………………………………………………………6 Journals: Tables of Contents…………………………………………………………………………….7 Obstetrics and Gynaecology British Journal of Obstetrics and Gynaecology American Journal of Obstetrics and Gynecology Exercise: Sensitivity
    [Show full text]
  • Anaesthesiology Update
    Hull and East Yorkshire Hospitals NHS Trust Anaesthesiology Update November 2018 You may need an NHS OpenAthens username and password to access the full text links. (Register here - https://openathens.nice.org.uk/ ) Alternatively you can request an article from Knowledge Services using this link: https://www.surveymonkey.co.uk/r/ILLs To allow us to continue to produce these bulletins, we really need your feedback. Please use this short evaluation form: https://www.surveymonkey.co.uk/r/X99JBWZ [email protected] Latest from the Cochrane Database of Systematic Reviews Pre‐emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery Brett Doleman, Jo Leonardi‐Bee, Thomas P Heinink, Debamita Bhattacharjee, Jon N Lund, John P Williams Abstract - Background Postoperative pain is a common consequence of surgery and can have deleterious effects. It has been suggested that the administration of opioid analgesia before a painful stimulus may improve pain control. This can be done in two ways. We defined 'preventive opioids' as opioids administered before i… Adverse side effects of dexamethasone in surgical patients Jorinde AW Polderman, Violet Farhang‐Razi, Susan Van Dieren, Peter Kranke, J Hans DeVries, Markus W Hollmann, Benedikt Preckel, Jeroen Hermanides Abstract - Background In the perioperative period, dexamethasone is widely and effectively used for prophylaxis of postoperative nausea and vomiting (PONV), for pain management, and to facilitate early discharge after ambulatory surgery. Long‐term treatment with steroids has many side effects, such as adrenal insufficien… Laryngeal mask airway versus endotracheal tube for percutaneous dilatational tracheostomy in critically ill adults Reinhard Strametz, Martin N Bergold, Tobias Weberschock Abstract - Background Percutaneous dilatational tracheostomy (PDT) is one of the most common bedside surgical procedures performed in critically ill adults, on intensive care units (ICUs), who require long‐ term ventilation.
    [Show full text]
  • Use of Local Anaesthetics and Adjuncts for Spinal and Epidural
    Wahlen et al. BMC Anesthesiology 2010, 10:4 http://www.biomedcentral.com/1471-2253/10/4 RESEARCH ARTICLE Open Access UseResearch of article local anaesthetics and adjuncts for spinal and epidural anaesthesia and analgesia at German and Austrian University Hospitals: an online survey to assess current standard practice Bianca M Wahlen*†1, Norbert Roewer†2 and Peter Kranke†3 Abstract Background: The present anonymous multicenter online survey was conducted to evaluate the application of regional anaesthesia techniques as well as the used local anaesthetics and adjuncts at German and Austrian university hospitals. Methods: 39 university hospitals were requested to fill in an online questionnaire, to determine the kind of regional anaesthesia and preferred drugs in urology, obstetrics and gynaecology. Results: 33 hospitals responded. No regional anaesthesia is conducted in 47% of the minor gynaecological and 44% of the urological operations; plain bupivacaine 0.5% is used in 38% and 47% respectively. In transurethral resections of the prostate and bladder no regional anaesthesia is used in 3% of the responding hospitals, whereas plain bupivacaine 0.5% is used in more than 90%. Regional anaesthesia is only used in selected major gynaecological and urological operations. On the contrary to the smaller operations, the survey revealed a large variety of used drugs and mixtures. Almost 80% prefer plain bupivacaine or ropivacaine 0.5% in spinal anaesthesia in caesarean section. Similarly to the use of drugs in major urological and gynaecological operations a wide range of drugs and adjuncts is used in epidural anaesthesia in caesarean section and spontaneous delivery. Conclusions: Our results indicate a certain agreement in short operations in spinal anaesthesia.
    [Show full text]
  • Labour Analgesia - Epidural Or Alternatives ?
    Labour analgesia - epidural or alternatives ? Thierry Girard Basel, Switzerland CONFLICT OF INTEREST Smiths-medical Cochrane Database Syst Rev. 2011;(12):CD000331. Epidural versus non-epidural or no analgesia in labour (Review) Anim-Somuah M, Smyth RMD, Jones L This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2011, Issue 12 http://www.thecochranelibrary.com Epidural versus non-epidural or no analgesia in labour (Review) Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Inhaled analgesia for pain management in labour (Review) Authors’ conclusions Klomp T, van Poppel M, Jones L, Lazet J, Di Nisio M, Lagro-Janssen ALM Inhaled analgesia appears to be effective in reducing pain intensity and in giving pain relief in labour. ... nitrous oxide appears to result in even more side effects such as nausea, vomiting, dizziness and drowsiness... This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2012, Issue 9 http://www.thecochranelibrary.com Inhaled analgesia for pain management in labour (Review) Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. http://tinycheese.blogspot.com/2010_06_01_archive.html INCREDIBLE PAIN continued all night - I eventually got on Remifentanil - the new morphine based drug which you self-administer, dosing yourself when you need it. It was absolutely WONDERFUL. Didn't actually stop you feeling pain but does stop you caring about it. I got absolutely sky high, thoroughly amused the midwife by talking utter rubbish, …., I even started seeing things - including Nelson Mandela on a bicycle..
    [Show full text]
  • WCA 2016 Programme Overview.Pdf
    16 th World Congress of Anaesthesiologists 28 August – 2 September 2016 Hong Kong Convention and Exhibition Centre FINAL PROGRAMME Rapid recovery. Efficient patient throughput. 1 Rapid Recovery impacts your patients and improves PACU efficiency.1,2 DESFLURANE PRESCRIBING INFORMATION This prescribing information is based on the HK Package Insert and is intended for international use only. Please always consult your full country-specific SPC as licenses and licensing conditions may vary from country to country. Name and composition: Desflurane 100% v/v Inhalation vapour, liquid. Indications: Inhalation agent for induction and/or maintenance of anaesthesia in adults, maintenance of anaesthesia in paediatrics. Dosage and Route: See SPC for full details. Administration by inhalation using vapouriser specifically designed for use with desflurane and dose individual- ised based on patient’s response. MAC decreases with increasing age. Induction: End-tidal concentrations of 4-11% usually produces surgical anaesthesia in 2-4 minutes. Not for induction in paediatrics. Maintenance: 2.5-8.5% with or without concomitant nitrous oxide. 5.2-10% with or without nitrous oxide in paediatrics. Not for use in non-intubated children. Concentrations of 1-4% have been used successfully in chronic renal/hepatic impairment and renal transplant. Side effects: Nausea and vomiting has been reported postoperatively – may be due to a range of factors and common following surgery under general anaesthesia. Common (≥1/100 - <1/10) Pharyngitis, breath holding, headache, conjunctivitis, nodal arrhythmia, bradycardia, tachycardia, hypertension, apnea, cough, laryngospasm, salivary hypersecretion. Precautions: Only to be administered by people trained in administration of general anaesthesia with appropriate emergency measures available.
    [Show full text]
  • PRELIMINARY PROGRAMME Programme
    PRELIMINARY PROGRAMME Pre-congress Courses and Workshops Access is limited to pre-registered delegates Programme AIRCC Pre-Congress Course on current concepts in airway management organised Pre-Congress Course by the ESA Scientific Subcommittee on Respiration and Airway Management, in collaboration with the European Airway Management Society (EAMS) **IMPORTANT NOTICE: access is limited to pre-registered delegates Chairs: Arnd Timmermann (Berlin, Germany) Lorenz Theiler (Bern, Switzerland) Introduction Arnd Timmermann (Berlin, Germany) Lorenz Theiler (Bern, Switzerland) Welcome Ellen P. O'Sullivan (Dublin, Ireland) Robert Greif (Bern, Switzerland) Morbidity and mortality of the airway management Ellen P. O'Sullivan (Dublin, Ireland) Pre-operative assessment and strategies Carin Hagberg (Houston, United States) Break Workshop Part 1 - 3 Skillstations Break Case 1: Pushing the limits? (2nd G SGA) Case 2: Oxygen yes – tube no (Videolaryngoscopy) Lorenz Theiler (Bern, Switzerland) Case 3: Plan ahead (Awake intubation) Arnd Timmermann (Berlin, Germany) Lunch Workshop Part 2 - 3 Skillstations Case 4: When all things go wrong Ankie Hamaekers (Maastricht, Netherlands) Case 5: Small airway – big problem? (The pediatric difficult airway) Rolf Holm-Knudsen (Copenhagen, Denmark) Interactive case report Break Workshop Part 3 - 3 Skillstations Summary statements and closing remarks Arnd Timmermann (Berlin, Germany) Lorenz Theiler (Bern, Switzerland) Skill Stations 1 1. Supraglottic devices and mask ventilation Anil Patel (London, United Kingdom) Ana Maria Lopez Gutiérrez (Barcelona, Spain) 2. Flexible optical laryngoscopy Carin Hagberg (Houston, United States) Massimiliano Sorbello (Catania, Italy) Kamil Toker (Kocaeli, Turkey) Ellen P. O'Sullivan (Dublin, Ireland) 3. Intubation through supraglottic device Elizabeth Behringer (Los Angeles, United States) Hulya Bilgin (Bursa, Turkey) 4. Direct laryngoscopy and stylets Robert Greif (Bern, Switzerland) Peter Paal (Innsbruck, Austria) 5A.
    [Show full text]